You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Regulatory News

Regulatory News MoCRA for Cosmetic Powder Ingredients: FDA

KingPowder Technical Team 194

The United States has no pre-market approval for cosmetics. That single fact shapes every conversation about exporting powders there, and it is also the reason the 2022 Modernization of Cosmetics Regulation Act (MoCRA) matters so much: it did not introduce approval, but it replaced a largely voluntary system with registered facilities, listed products and substantiated safety files.

1. The baseline: cosmetics are regulated as cosmetics

Under the FD&C Act, a cosmetic is an article intended to be applied to the human body for cleansing, beautifying or altering appearance. A mineral powder sold as a cosmetic ingredient is regulated through the finished product it goes into, not through a pre-market licence of its own.

Two colour additives are the classic exception. If a powder is also a colour additive — titanium dioxide is the usual example — its use is subject to the colour additive provisions, which are stricter than the general cosmetic provisions. Confirm the intended use with the brand before assuming the lighter pathway applies.

2. What MoCRA added

MoCRA was signed in December 2022 and created four obligations that touch ingredient suppliers indirectly but unmistakably:

  • Facility registration.Facilities that manufacture or process cosmetic products for US distribution must register with FDA. Registration is not approval, but an unregistered facility is a compliance failure for the brand.
  • Product listing.Each marketed cosmetic product must be listed, with its ingredients. This is where an ingredient name that differs from the INCI name causes trouble.
  • Adverse event reporting.Serious adverse events must be reported within a defined window, and the brand will expect traceability down to the batch.
  • Safety substantiation.The brand must hold adequate evidence that the product is safe. For a powder, that evidence is assembled from supplier data: composition, impurities, particle size, and the exposure assessment.

Note the direction of the obligations: they sit on the brand and the facility, not on the mineral supplier. What a supplier controls is whether the brand can satisfy them, and that is where documentation becomes commercial.

3. Talc is the one place where a specific ingredient rule exists

Talc has been the subject of sustained attention because of asbestos contamination in historical supply chains. FDA has been developing a standardised testing method for asbestos in talc-containing cosmetic products. For any talc grade destined for the US, assume the buyer will require:

  • A non-asbestos declaration referencing a named analytical method, not a generic sentence.
  • Batch-level test data rather than a one-off certificate.
  • Mine or source identification, because the geological origin is what drives the risk.

The same logic is spreading to other mineral powders even where no specific rule exists. Buyers of mica, kaolin and silica increasingly ask for the same declarations as a matter of procurement policy.

4. Ingredient naming and the INCI trap

Product listing requires ingredients to be declared. Where a supplier's commercial name does not map cleanly onto an INCI name, the brand either lists something wrong or spends weeks resolving it. Supply the INCI name for every component, including treatment agents, alongside the trade name.

This is also where "proprietary treatment" language backfires. A brand cannot list an undisclosed treatment agent, so an unnamed treatment becomes a listing blocker.

5. Documents a US buyer will actually ask for

Item Why it is asked for
INCI names for all components Product listing cannot be completed without them
Safety Data Sheet (GHS) Hazard communication and internal safety review
Heavy metal and microbiological data Feeds the safety substantiation file
Non-asbestos declaration (talc) Named method, batch-linked
Batch traceability Required for adverse event investigation

6. What this means commercially

MoCRA did not make the US market harder to enter; it made it harder to enter with thin documentation. A supplier who can hand over INCI-mapped composition, batch-level impurity data and a method-specific asbestos declaration for talc is removing work from the brand's compliance team. In a market with no pre-market approval, that documentation is the barrier to entry.

US requirements under MoCRA continue to be implemented through guidance and rulemaking. Verify current obligations with the brand or a US regulatory consultant before shipping; the framework above is stable, the specific deadlines are not.

Become a Distributor